<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">Inflammatory bowel disease</z:e> (IBD) is a <z:hpo ids='HP_0011010'>chronic</z:hpo> illness caused by complex interactions between genetic and environmental factors that propagate <z:mp ids='MP_0001845'>inflammation</z:mp> and damage to the gastrointestinal epithelium </plain></SENT>
<SENT sid="1" pm="."><plain>This state of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> increases the risk for development of <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in IBD patients </plain></SENT>
<SENT sid="2" pm="."><plain>Thus, the development of targeted therapeutics that can disrupt the cycle of <z:mp ids='MP_0001845'>inflammation</z:mp> and epithelial injury is highly attractive </plain></SENT>
<SENT sid="3" pm="."><plain>However, such biological therapies, including those targeting epidermal growth factor receptor pathways, pose a risk of increasing <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> rates </plain></SENT>
<SENT sid="4" pm="."><plain>Using two mouse models of <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, we found that epidermal growth factor receptor inactivation accelerated the incidence and progression of <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>By modulating <z:mp ids='MP_0001845'>inflammation</z:mp> and epithelial regeneration, epidermal growth factor receptor optimized the response to <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> and limited subsequent <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>These findings provide important insights into the pathogenesis of <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and suggest that epidermal growth factor-based therapies for IBD may reduce long-term <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk </plain></SENT>
</text></document>